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Relationship between muscle strength and 
motor function in Duchenne muscular dystrophy
Relação entre força muscular e função motora na distrofia muscular de Duchenne
Milene F. Nunes1, Michele E. Hukuda1, Francis M. Favero2, Acary B. Oliveira2, Mariana C. Voos1, Fátima A. Caromano1
In the last years, the importance of accurate, reliable and 
sensitive outcome measures in patients with Duchenne mus-
cular dystrophy (DMD) has been outlined1,2,3. Motor function 
is, currently, the main outcome measure (e.g. Motor Function 
Measure, MFM2,4,5, six-minute walking test6 and North Star am-
bulatory assessment7,8). However, motor function scores can be 
complemented by clinical measures, such as muscle strength, 
evaluated by the Medical Research Council scale (MRC)9,10,11,12,13, 
to provide more detailed monitoring of disease progression2,3.
In DMD, muscle strength is assessed to describe weakness 
topography and disease progression rate. This knowledge con-
tributes to the rationale for therapeutic interventions, e.g. to 
test treatment (medication, orthoses) efficacy, facing DMD 
progression14. MRC involves manual muscle testing, which is 
a procedure to evaluate the strength of muscle groups, based 
on the performance of a movement, in relation to the manual 
resistance and gravity force9,10,11,12,13. 
The ability to overcome the maximum resistance applied 
within the possible range of motion (considering that some pa-
tients have joint and muscle retractions) is scored as 5. The abil-
ity to overcome partial resistance is scored as 4. The ability to 
overcome gravity within the possible range of motion is scored 
as 3. The ability to move partially, with lower amplitude than 
the possible passive range of motion is scored as 2. The ability 
to contract muscles, without joint movement, is scored as 1. 
The absence of muscle contraction is scored as zero. Therefore, 
MRC ranges from 5 to 0, with 5 being normal strength and 0 be-
ing no observable muscle contraction9,10,11,12,13.
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AbstRACt
Measuring muscle strength and motor function is part of Duchenne muscular dystrophy (DMD) assessment. However, the relationship 
between these variables is controversial. Objective: To investigate the relationship between muscle strength and motor function and 
between these variables and age. Method: Muscle strength was measured by Medical Research Council (MRC) scale and motor function, 
by Motor Function Measure (MFM), in 40 non-ambulatory patients. Spearman tests investigated the relationships between muscle strength, 
motor function and age. Results: Total MRC and MFM scores were strongly related to each other (r = 0.94; p < 0.001), but not to age (r = -0.19, 
r = -0.31, respectively; p > 0.05). Strong and moderate relationships between partial muscle strength and motor function scores were found. 
Higher correlation coefficients were found between total scores and Dimensions 2 (axial/ proximal control) and 3 (distal control) of MFM. 
Conclusion: Muscle strength and motor function are strongly correlated and seem to decrease proportionally in DMD.
Keywords: muscular dystrophy, Duchenne; motor activity; motor skills; muscle strength; Statistics, Nonparametric.
Resumo
Mensurar força muscular e função motora é parte da avaliação em distrofia muscular de Duchenne (DMD). A relação entre essas variáveis 
é controversa. Objetivo: Investigar a relação entre força muscular, função motora e idade.  Método: Força muscular foi medida pela Medical 
Research Council (MRC), e função motora pela escala Medida da Função Motora (MFM), em 40 pacientes cadeirantes. Teste de Spearman 
investigou as relações entre força muscular, função motora e idade. Resultados: O escore total da escala MRC e da MFM foram fortemente 
relacionados entre si (r = 0,94; p < 0,001), mas não com a idade (r = -0,19; r = -0,31, respectivamente; p > 0,05). Foram encontradas correlações 
fortes e moderadas entre os escores parciais de força muscular e função motora. As relações mais fortes ocorreram entre os escores totais, 
Dimensão 2 (controle axial/proximal) e 3 (controle distal) da escala MFM. Conclusão: Força muscular e função motora estão fortemente 
correlacionadas e parecem diminuir proporcionalmente na DMD.
Palavras-chave: distrofia muscular de Duchenne; atividade motora; destreza motora; força muscular; estatísticas não paramétricas.
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The validity of MRC has been determined in litera-
ture9,10,11,12. However, some studies11,14,15 considered the scale 
subjective and, therefore, therapist-dependent. This occurred 
because MRC score is provided by the therapists’ clinical vi-
sual and manual perception of movement15. For instance, the 
amount of manual resistance applied to differ score 4 (mod-
erate resistance) from 5 (strong resistance) is subjective and 
may differ among therapists.
MRC also allows the calculation of partial scores. The 
proximal upper limb score involves shoulder flexors, exten-
sors, abductors, adductors, internal and external rotators 
strength. The distal upper limb score involves elbow flexors 
and extensors, supinators and pronators and wrist flexors 
and extensors strength. The proximal lower limb score in-
cludes hip flexors, extensors, abductors, adductors, internal 
and external rotators strength. The distal lower limb score 
includes knee flexors and extensors and ankle dorsiflexors, 
plantar flexors, invertors and eversors strength9.
MFM was validated in Portuguese5. It has high reliabil-
ity and responsiveness2,4,5. It assesses motor function and is 
applicable to both ambulatory and wheelchair-dependent 
patients. Dimension 1 assesses standing position and trans-
fers, Dimension 2 evaluates axial and proximal motor func-
tion and Dimension 3 evaluates distal motor function. The 
information provided by functional scales, e.g. MFM, is fun-
damental to assess and follow patients with DMD.
However, the primary problem in DMD, which disrupts 
motor function, is muscle strength. The muscle contractile 
property is reduced, due to the deterioration occurred in the 
absence of dystrophin. Despite having some muscle strength 
tests (head, hip and ankle flexion against gravity), the MFM 
does not employ manual resistance, nor focuses on specific 
muscle groups contraction, because the main scope is mea-
suring function.
The decrease in functional dependence (detected by 
MFM2,4,5, six-minute walking test6 and/or North Star ambulato-
ry assessment7,8) has been associated to the reduction of muscle 
mass16 and muscle strength17.  However, the relationship between 
muscle strength and motor function in patients with DMD has 
not been quantified, nor discussed in the literature. The studies 
that investigated the relationship between muscle strength and 
motor function included heterogeneous populations with neu-
romuscular diseases12,18, assessed few muscle groups1,12,19 and/or 
did not include all the domains of MFM19.
Besides, the findings have been contradictory. Vuillerot 
et al.2 stated that muscle strength and motor function were 
not related because many other factors, e.g. range of mo-
tion and pain, influenced motor control. Conversely, Scott 
et al.9 reported that the relationship between muscle strength 
and motor function differed among age groups and level of 
wheelchair dependence. They established patterns of DMD 
progression, which could serve as references. They fol-
lowed 61 patients with DMD for three years and assessed 
the total muscle strength, with MRC scale, and the motor 
function, evaluated by Hammersmith Motor Assessment 
Scale (HMAS), a scale with 20 functional activities. The de-
cline of muscle strength was related to age increase and mo-
tor function loss9.
The knowledge of how muscle strength (including the to-
tal MRC score and the upper and lower limbs partial scores) 
and motor function (including the total MFM score and the 
Dimensions scores) are related may be helpful for researchers 
and therapists in data interpreting and clinical decision-making. 
Our primary aim was to investigate the relationship between 
muscle strength, assessed by the total and partial scores of MRC 
and motor function, assessed by the total and partial scores of 
MFM in patients with DMD. Our secondary aim was to investi-
gate the relationship between these variables and age.
metHoDs
subjects
This is a cross-sectional study, approved by the Research 
Ethics Committee of Universidade Federal de São Paulo. It in-
cluded 40 non-ambulatory patients, from 12 to 30 years of age, 
classified from 7 to 9 with the Vignos scale20, receiving mul-
tidisciplinary assistance at Brazilian Association of Muscular 
Dystrophy. The diagnosis of DMD was confirmed by DNA anal-
ysis and/or muscular biopsy with histochemical or immuno-
histochemical study). Corticosteroid therapy was prescribed 
according to the international consensus21. All participating 
therapists had a minimum of two years experience with pa-
tients with DMD and specific training on the scales used.
Muscle strength was assessed with the MRC scale and mo-
tor function was assessed with the MFM, by physiotherapists 
from the Brazilian Association of Muscular Dystrophy, who 
had two or more years practice with assessment and treatment 
of patients with DMD. Patients unable to understand verbal 
commands or presenting any additional clinical or motor im-
pairment that contraindicated the assessment with MRC scale 
and MFM were excluded. The order between muscle strength 
and motor function assessment protocol and the therapists 
assessing scales and patients were randomized.
Procedures
Assessment with MRC and MFM
MRC tests muscle strength by employing manual resis-
tance, with the patient lying on dorsal, ventral, lateral de-
cubitus and on sitting position. Both left and right sides 
are tested, to minimize dominance influences and possible 
asymmetrical involvement of the muscle groups. Shoulder 
flexors, extensors, abductors, adductors, internal and exter-
nal rotators; elbow flexors and extensors, supinators, pro-
nators; wrist flexors and extensors; hip flexors, extensors, 
abductors, adductors, internal and external rotators; knee 
flexors and extensors; ankle dorsiflexors, plantar flexors, 
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invertors and eversors are evaluated. The best score obtained 
(comparing both sides) is registered. 
The muscle strength is graded from zero to five. Zero means 
no contraction; one indicates flicker or trace of contraction; 
two denotes the existence of active movement; three means 
active movement against gravity; four indicates active move-
ment against gravity and manual resistance; five is used for nor-
mal strength. Scott et al.9 defined the MRC index. In the present 
study, the indexes were also calculated, using the formula: 
MRC (%) =   Total muscle strength * 100     
            Number of tested muscles * 5
The proximal upper limbs scores (involving shoulder flexors, 
extensors, abductors, adductors, internal and external rotators), 
the distal upper limbs scores (involving elbow flexors and exten-
sors, supinators and pronator and wrist flexors and extensors), 
the proximal lower limbs scores (hip flexors, extensors, abduc-
tors, adductors, internal and external rotators) and the distal 
lower limbs scores (knee flexors and extensors and ankle dorsi-
flexors, plantar flexors, invertors and eversors) were calculated.
The Brazilian Portuguese version of MFM was used5. The 
scale includes 32 items, subdivided into three dimensions. 
Dimension 1 assesses the standing position and transfers 
(13 items); Dimension 2 assesses the axial and proximal limb 
motor function (12 items); and Dimension 3 tests distal limb 
motor function (7 items, 6 of which involving the upper limbs). 
Each item is scored from zero to three. Percentages are used 
to represent the scores on each Dimension and the total score.
Data analysis
Correlation analyses tested the relationships between 
motor function (MFM, Dimensions 1, 2 and 3 and total score) 
and muscle strength (MRC upper and lower limbs proximal 
score, MRC upper and lower limbs distal score and MRC total 
score). The possibility of relationship between these variables 
and age was also investigated.
As MFM provided ordinal variables and data displayed 
non-normal distribution, Spearman tests were used (Statistica 
12.0). Significance level was set at alfa ≤ 0.05). Correlations 
were considered strong when r ≥ 0.80 and moderate when 0.40 
≤ r ≤ 0.79.
ResuLts
Age ranged from 12 to 30 (median 18), Vignos ranged from 7 
to 9 (median 7). Table shows Spearman correlation coefficients 
obtained by correlating MRC total and partial scores (muscle 
strength) to MFM total and partial scores (motor function). The 
total scores of muscle strength and motor function were strongly 
correlated (r = 0.94; p < 0.001), but not to age (r = -0.19; p = 0.831 
and r = -0.31; p = 0.102, respectively). Patients with higher muscle 
strength scores also showed higher motor function scores (Table). 
Muscle strength and motor function showed moderate to strong 
relationships to each other, but not to age.
DIsCussIoN
In the present study we found moderate to strong rela-
tionships between motor function and muscle strength in a 
sample of 40 patients with DMD. However, motor function 
and muscle strength were not related to age. This means that 
a considerable variability of muscle strength and motor func-
tion can be observed among different ages.
Benaïm et al.18 investigated the correlation between 
muscle strength and motor function, using MRC and MFM, 
respectively. Patients aged 18–78 years, with neuromuscular 
diseases, e.g. myotonic dystrophy and facioscapulohumeral 
dystrophy were assessed. The total and partial scores of MFM 
were correlated to MRC total score and partial indexes. The 
authors considered MRC useful to provide more specific data 
and to complement MFM. However, the study did not pro-
vide specific data about patients with DMD, and focused on 
neuromuscular diseases in general.
In 2012, Diniz et al.19 investigated the muscle strength and 
motor function of 20 patients with DMD. They found moderate 
to strong correlations between MRC scores and all Dimensions 
of MFM. However, they assessed only the muscle strength of 
shoulders, elbows, wrists, hips, knees and ankles flexors and 
extensors. Therefore, we believe that the present study ampli-
fies the data and discussion of Diniz et al.19, because we evalu-
ated a higher number of muscle groups and a higher sample.
Table. Relationship between muscle strength Medical Research Council (MRC) scale, Motor Function Measure (MFM) and age 
(years): Spearman correlation coefficients (r).
Variables
MFM 
Age 
Total score Dimension1 Dimension2 Dimension3
Total muscle strength 0.94** 0.62* 0.92** 0.87** -0.19
Upper limbs proximal muscle strength 0.92** 0.55* 0.90** 0.85** -0.35
Lower limbs proximal muscle strength 0.76* 0.53* 0.79* 0.69* -0.11
Upper limbs distal muscle strength 0.89** 0.60* 0.85** 0.88** -0.20
Lower limbs distal muscle strength 0.79* 0.60* 0.78* 0.77* -0.04
Age -0.31 -0.33 -0.34 -0.25 -
Strong correlations are marked with ** and moderate correlations with *; p ≤ 0.05 for all marked (strong and moderate) correlation coefficients. MFM: Motor 
Function Measure. Medical Research Council formulas were used to calculate total and partial muscle strength scores.
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The strong relationships between muscle strength and mo-
tor function found in the present study differs from the studies 
of Beenakker et al.15 and Parreira et al.13 Beenakker et al.15 state 
that, during the progression of DMD, high functional chang-
es can be associated to little deterioration of muscle strength. 
The differences found between the study of Beenakker et al.15 
and ours can be attributed to the method of motor function 
and muscle strength assessment and sample characteristics. 
Beenakker et al.15 evaluated motor function with timed scores, 
which are highly variable in patients with DMD22,23 and muscle 
strength with dynamometry24, which allows the inclusion of 
only a reduced number of muscle groups. Besides, Beenakker 
et al.15 studied ambulatory patients (aged 5–8 yrs) and, in the 
present study, we included only non-ambulatory patients 
(aged 12–30 yrs). Therefore, the relationships between muscle 
strength and motor function can be different in ambulatory 
and non-ambulatory patients.
In 2010, Parreira et al.13 compared the progression of mus-
cle strength (assessed by MRC) and motor function (evalu-
ated by Hammersmith Motor Assessment Scale), of patients 
with DMD treated with the sample described by Scott et al.9, 
of non-treated patients. They concluded that, among patients 
treated with steroids, the progression of DMD was slower in all 
age groups evaluated. They also stated that muscle strength 
tended to be proportionally more compromised than motor 
function. This information is in disagreement with our find-
ings, which show that muscle strength seems to be as com-
promised as motor function, because they are strongly related.
We found that the total muscle strength was strongly re-
lated to the total score of MFM (r = 0.94; p < 0.001), Dimension 
2 (r = 0.92; p < 0.001) and Dimension 3 of MFM (r = 0.87; 
p < 0.001). The performance on transferring and stabilizing 
the trunk, measured by Dimension 2 and the performance on 
distal motor tasks, measured by Dimension 3, were strong-
ly related to the total muscle strength. This suggests that 
transferring capacity, trunk control and upper limbs dexter-
ity can differentiate patients with DMD with Vignos 7-9 and 
vary proportionally to the global muscle strength condition. 
Conversely, the total muscle strength was moderately related 
to Dimension 1 of MFM (r = 0.62; p= 0.021). The performance 
on standing and locomotion, measured by Dimension 1, was 
compromised in most patients, which caused a floor effect in 
this section and resulted on a lower correlation coefficient. 
It is interesting to note that the proximal upper limbs 
strength was not only related to Dimension 2 of MFM, 
which evaluates tasks involving trunk muscles (r = 0.90; 
p < 0.001), but also to the total score (r = 0.92; p < 0.001) and 
to Dimension 3 of MFM, which involves distal motor control 
(r = 0.85; p < 0.001) (Table). The upper limbs distal muscle 
strength was also strongly related to Dimensions 2 and 3 and 
to the total score of MFM (r = 0.85; r = 0.88; r = 0.89, respec-
tively; p < 0.001 for all coefficients) (Table). Therefore, better 
proximal strength on upper limbs resulted on better trunk 
and shoulders stability, also leading to better distal function.
Bartels et al.1 assessed the upper limbs of patients with 
DMD with Dimension 3, MRC, dynamometry and goniom-
etry. They concluded that, although the preservation of mus-
cle strength and range of motion influenced distal motor 
function, there was great variability in these three variables. 
Dimension 3 assesses distal motor function and is more re-
lated to the distal muscle strength of upper limbs. From sev-
en tasks evaluated on this Dimension, six are related to up-
per limbs functions and only one to lower limbs functions 
(ankle plantar and dorsal flexion assessment). Diniz et al.19 
found strong correlations between upper limbs distal muscle 
strength and Dimension 3 (r = 0.80; p = 0.002). In the present 
study, we found even higher correlation (r = 0.88; p < 0.001), 
although we tested the strength of a higher number of mus-
cles and on a more homogeneous population (Vignos 7–9)20.
Considering the lower limbs strength, we found that the 
proximal and the distal strength were moderately related 
to the total score (r = 0.76; p < 0.001 and r = 0.79; p < 0.001, 
respectively) and to Dimension 3 (r = 0.69; p < 0.001 and r = 0.77; 
p < 0.001, respectively) (Table). We found moderate correla-
tions between lower limbs proximal and distal strength and 
Dimension 1 (r = 0.53, p = 0.031; r = 0.60; p = 0.020, respectively). 
Diniz et al.19 found a stronger correlation between the lower 
limbs proximal muscle strength and Dimension 1 (r = 0.90, 
p < 0.001). They included patients with lower Vignos scores 
and higher functional performance. Therefore, some patients 
had better proximal lower limbs strength, which may have 
contributed to this higher relationship.
In the present study, lower limbs proximal strength was 
strongly related to Dimension 2 (r = 0.80; p < 0.001) and 
moderately related to lower limbs distal strength (r = 0.78; 
p = 0.001) (Table). Proximal and distal strength of lower limbs 
are fundamental to stabilize trunk and lower limbs when 
the patient is performing the transferring and trunk support 
tasks from Dimension 2.
Age was not correlated to muscle strength, nor to motor 
function (Table). This means that age cannot be used to infer 
muscle strength loss in DMD and should not be used to mon-
itor these patients. The genetic heterogeneity in DMD can ex-
plain the clinical heterogeneity25. Age is not related to DMD 
milestones and should not be the only variable used to moni-
tor DMD progression. Not only the losses of muscle strength 
and motor function, but also their consequences, such as fa-
tigue and joints contractures, vary broadly among specific 
age groups of patients with DMD26,27. 
Recent studies elaborated and applied functional scales 
to assess patients with DMD sitting and standing from a 
chair, using the Functional Evaluation Scale for DMD. They 
showed weak or no correlation between the scores on sit-
ting on the chair (r = 0.44; p = 0.018) and rising from the 
chair (r = 0.05; p = 0.830) and age28 and between the scores 
on climbing up (r = 0.59; p = 0.004) and climbing down steps 
(r = 0.50; p = 0.005) and age29. The progression of DMD dif-
fered highly among patients28.
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The highest correlation coefficient found was between 
the total score of MFM and the total muscle strength index 
(r = 0.94, p < 0.001). This high coefficient shows the impor-
tance of not focusing only on specific muscle groups, but 
considering the overall motor condition of the patient on 
decision-making involving motor function.
Many studies have used functional scales, instead of 
MRC, to assess patients with neuromuscular diseases, due 
to MRC subjectivity11,12,13,14,15. For instance, Vuillerot et al.30 
showed that the MFM was useful to detect mobility loss and 
functional dependence increase. It predicted gait loss with-
in a year, when Dimension 1 was 40% or lower30. Conversely, 
Bakker et al.26 showed that MRC provided good references for 
DMD prognosis. When hip extensors were classified as 2 or 
lower and when dorsiflexors were scored below 4, there was 
higher risk of gait loss within two years. 
Moreover, the present study found stronger relation-
ships between muscle strength and MFM than previous 
studies13,15,18,19. This fact can be attributed to the extensive 
practice with patients with DMD of all the examiners that 
participated in this study. This may have eliminated the sub-
jectivity of MRC, e.g. the amount of manual resistance ap-
plied to differ score 4 (moderate resistance) from 5 (strong 
resistance), because, with extensive practice, therapists be-
come able to adjust the amount of manual resistance given to 
patients with severe weakness. For this reason, we observed 
that a more subjective scale, as MRC, was related to a more 
standardized, valid and reproducible scale, as the MFM11,12.
As we only included patients with Vignos 7-9, future stud-
ies should investigate the relationship of muscle strength and 
motor function in ambulatory patients. The present study 
evidenced moderate to strong correlations between muscle 
strength and motor function, evaluated by MRC and MFM, 
in non-ambulatory DMD patients. It is possible to infer that 
non-ambulatory patients with lower muscle strength will 
also show lower motor function.
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